Highbridge Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-223,057
Closed -$9.33M 474
2018
Q3
$9.33M Buy
+223,057
New +$8.59M 0.22% 125
2017
Q3
Sell
-6,617
Closed -$213K 1725
2017
Q2
$211K Sell
6,617
-309,583
-98% -$9.76M ﹤0.01% 1095
2017
Q1
$10.3M Buy
+316,200
New +$9.97M 0.15% 178
2016
Q4
Sell
-7,905
Closed -$241K 1518
2016
Q3
$254K Sell
7,905
-127,604
-94% -$4.27M ﹤0.01% 1077
2016
Q2
$4.53M Buy
135,509
+116,221
+603% +$3.71M 0.07% 277
2016
Q1
$542K Buy
19,288
+9,028
+88% +$258K 0.01% 952
2015
Q4
$314K Sell
10,260
-533,961
-98% -$16.8M ﹤0.01% 1172
2015
Q3
$16.2M Buy
544,221
+378,874
+229% +$12.1M 0.25% 106
2015
Q2
$5.26M Sell
165,347
-921,997
-85% -$30M 0.07% 295
2015
Q1
$35.9M Buy
+1,087,344
New +$34.6M 0.5% 46
2014
Q4
Sell
-2,018,773
Closed -$57.9M 1372
2014
Q3
$56.6M Sell
2,018,773
-39,265
-2% -$1.1M 0.75% 19
2014
Q2
$58M Buy
2,058,038
+280,619
+16% +$8M 0.71% 17
2014
Q1
$54.2M Buy
1,777,419
+41,773
+2% +$1.25M 0.68% 30
2013
Q4
$50.4M Buy
1,735,646
+334,414
+24% +$9.73M 0.6% 33
2013
Q3
$38.2M Buy
1,401,232
+1,330,003
+1,867% +$36.2M 0.4% 58
2013
Q2
$1.89M Buy
+71,229
New +$1.97M 0.02% 511

Other funds holding PFE

Highbridge Capital Management's PFE Position: Q4 2018 in Review

Highbridge Capital Management sold out of Pfizer (PFE) in Q4 2018, closing a stake of 223,057 shares — an estimated $9.33M sold.

Highbridge Capital Management first reported a position in PFE in Q2 2013 and held it in 16 quarters. The position peaked at $58M in Q2 2014. 2,404 funds tracked by Wall St. Rank hold PFE as of Q4 2018.

  • Highbridge Capital Management reported no remaining Pfizer position as of Q4 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 223,057 Pfizer shares in Q4 2018, an estimated $9.33M.
  • Highbridge Capital Management first reported a position in Pfizer in Q2 2013 and held it in 16 quarters.
  • Highbridge Capital Management's Pfizer position peaked at $58M in Q2 2014.
  • 2,404 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.

Based on Highbridge Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.